Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer’s Disease

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

(2017) Joakim Hertze et al.   JOURNAL OF ALZHEIMERS DISEASE

Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer’s Disease Dementia

(2016) Salvatore Mazzeo et al.   JOURNAL OF ALZHEIMERS DISEASE

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

(2016) Rik Vandenberghe et al.   Alzheimers Research & Therapy

Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET

(2016) Danielle van Westen et al.   Scientific Reports

Amyloid PET Imaging in Lewy Body Disorders

(2015) Paul Donaghy et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Correlations Between Mini-Mental State Examination Score, Cerebrospinal Fluid Biomarkers, and Pathology Observed in Brain Biopsies of Patients With Normal-Pressure Hydrocephalus

(2015) Adila Elobeid et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus

(2015) Madoka Nakajima et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The case for rejecting the amyloid cascade hypothesis

(2015) Karl Herrup   NATURE NEUROSCIENCE

Brain structure and function as mediators of the effects of amyloid on memory

(2015) N. Mattsson et al.   NEUROLOGY

Impact of Cerebrospinal Fluid Shunting for Idiopathic Normal Pressure Hydrocephalus on the Amyloid Cascade

(2015) Masao Moriya et al.   PLoS One

Revisiting the Mechanisms of CNS Immune Privilege

(2015) Antoine Louveau et al.   TRENDS IN IMMUNOLOGY

Evaluation of coexistence of Alzheimer’s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers

(2014) Tae Sung Lim et al.   BMC Neurology

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias

(2014) David R. Howlett et al.   BRAIN PATHOLOGY

Profile of cognitive dysfunction and relation with gait disturbance in Normal Pressure Hydrocephalus

(2014) Paulo Bugalho et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy

(2014) E. Coppi et al.   NEUROLOGICAL SCIENCES

Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus

(2014) N. R. Graff-Radford   NEUROLOGY

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

(2014) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus

(2014) Okko T. Pyykkö et al.   PLoS One

Idiopathic normal-pressure hydrocephalus: Pathophysiology and diagnosis by CSF biomarkers

(2013) A. Jeppsson et al.   NEUROLOGY

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

Garbage Truck of the Brain

(2013) M. Nedergaard   SCIENCE

Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings

(2013) Meredith N. Braskie et al.   TRENDS IN COGNITIVE SCIENCES

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease

(2013) David J. Irwin et al.   Frontiers in Aging Neuroscience

Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus

(2012) M. Miyajima et al.   EUROPEAN JOURNAL OF NEUROLOGY

Relationship between Memory Performance and ß-Amyloid Deposition at Different Stages of Alzheimer’s Disease

(2012) Gaël Chételat et al.   Neurodegenerative Diseases

Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population

(2012) Marco Monaco et al.   NEUROLOGICAL SCIENCES

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid  

(2012) J. J. Iliff et al.   Science Translational Medicine

Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus

(2011) Andrew Tarnaris et al.   Alzheimers & Dementia

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab

(2011) Susanne Ostrowitzki   ARCHIVES OF NEUROLOGY

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus

(2011) Andrew Tarnaris et al.   JOURNAL OF NEUROSURGERY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

(2010) Ville Leinonen et al.   ANNALS OF NEUROLOGY

Amyloid and Tau accumulate in the brains of aged hydrocephalic rats

(2010) Gerald D. Silverberg et al.   BRAIN RESEARCH

Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau

(2010) Balmiki Ray et al.   JOURNAL OF PSYCHIATRIC RESEARCH

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

(2010) Juha O Rinne et al.   LANCET NEUROLOGY

Can Alzheimer disease be prevented by amyloid-β immunotherapy?

(2010) Cynthia A. Lemere et al.   Nature Reviews Neurology

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

(2009) Ian R. A. Mackenzie et al.   ACTA NEUROPATHOLOGICA

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

Total and phosphorylated tau protein as biological markers of Alzheimer’s disease

(2009) Harald Hampel et al.   EXPERIMENTAL GERONTOLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia

(2008) Gil D. Rabinovici et al.   ANNALS OF NEUROLOGY

Normal pressure hydrocephalus: Diagnosis and treatment

(2008) David Shprecher et al.   Current Neurology and Neuroscience Reports

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia